| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | XY body | 1.96e-04 | 23 | 19 | 2 | GO:0001741 | |
| GeneOntologyCellularComponent | sex chromosome | 7.24e-04 | 44 | 19 | 2 | GO:0000803 | |
| MousePheno | abnormal oocyte morphology | 1.96e-05 | 138 | 17 | 4 | MP:0001125 | |
| MousePheno | abnormal female germ cell morphology | 2.72e-05 | 150 | 17 | 4 | MP:0006361 | |
| MousePheno | abnormal oogenesis | 6.31e-05 | 186 | 17 | 4 | MP:0001931 | |
| MousePheno | abnormal zona pellucida morphology | 9.12e-05 | 12 | 17 | 2 | MP:0003696 | |
| MousePheno | infertility | 2.85e-04 | 1188 | 17 | 7 | MP:0001924 | |
| MousePheno | abnormal germ cell morphology | 6.12e-04 | 946 | 17 | 6 | MP:0002208 | |
| MousePheno | abnormal foam cell morphology | 6.40e-04 | 954 | 17 | 6 | MP:0009840 | |
| Domain | ZF_RING_1 | 3.01e-03 | 291 | 19 | 3 | PS00518 | |
| Domain | ZF_RING_2 | 3.22e-03 | 298 | 19 | 3 | PS50089 | |
| Domain | RING | 3.44e-03 | 305 | 19 | 3 | SM00184 | |
| Domain | Znf_RING | 4.15e-03 | 326 | 19 | 3 | IPR001841 | |
| Domain | Znf_C2H2-like | 7.61e-03 | 796 | 19 | 4 | IPR015880 | |
| Domain | Znf_C2H2 | 7.91e-03 | 805 | 19 | 4 | IPR007087 | |
| Domain | ZnF_C2H2 | 8.01e-03 | 808 | 19 | 4 | SM00355 | |
| Domain | - | 1.00e-02 | 449 | 19 | 3 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 1.07e-02 | 459 | 19 | 3 | IPR013083 | |
| Domain | Znf_RING_CS | 1.17e-02 | 163 | 19 | 2 | IPR017907 | |
| Domain | Znf_C3HC4_RING-type | 1.30e-02 | 172 | 19 | 2 | IPR018957 | |
| Domain | zf-C3HC4 | 2.12e-02 | 223 | 19 | 2 | PF00097 | |
| Pubmed | 4.24e-06 | 6 | 19 | 2 | 7487932 | ||
| Pubmed | 7.72e-06 | 71 | 19 | 3 | 33541421 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 1.31e-02 | 423 | 19 | 2 | chr12q13 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.99e-02 | 718 | 15 | 3 | 28 | |
| GeneFamily | Ring finger proteins | 2.12e-02 | 275 | 15 | 2 | 58 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500 | 6.93e-07 | 379 | 19 | 6 | gudmap_developingGonad_P2_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | 2.76e-06 | 770 | 19 | 7 | gudmap_developingGonad_P2_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | 1.73e-05 | 382 | 19 | 5 | gudmap_developingGonad_e14.5_ ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_500 | 2.38e-05 | 408 | 19 | 5 | gudmap_developingGonad_P2_testes_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | 4.21e-05 | 776 | 19 | 6 | gudmap_developingGonad_e14.5_ ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | 4.28e-05 | 778 | 19 | 6 | gudmap_developingGonad_e18.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 4.83e-05 | 795 | 19 | 6 | gudmap_developingGonad_e16.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | 3.39e-04 | 387 | 19 | 4 | gudmap_developingGonad_e18.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | 3.39e-04 | 387 | 19 | 4 | gudmap_developingGonad_e16.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_100 | 4.18e-04 | 34 | 19 | 2 | gudmap_developingGonad_e14.5_ ovary_100_k5 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_500 | 4.69e-04 | 36 | 19 | 2 | gudmap_developingGonad_P2_epididymis_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 5.51e-04 | 797 | 19 | 5 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_1000 | 6.24e-04 | 819 | 19 | 5 | gudmap_developingGonad_P2_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_500 | 7.34e-04 | 45 | 19 | 2 | gudmap_developingGonad_e16.5_epididymis_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_200 | 1.06e-03 | 54 | 19 | 2 | gudmap_developingGonad_e14.5_ ovary_200_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_500 | 1.48e-03 | 64 | 19 | 2 | gudmap_developingGonad_e16.5_ovary_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#2_top-relative-expression-ranked_500 | 1.53e-03 | 65 | 19 | 2 | gudmap_developingGonad_P2_ovary_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_500 | 1.62e-03 | 67 | 19 | 2 | gudmap_developingGonad_e18.5_epididymis_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_100 | 1.77e-03 | 70 | 19 | 2 | gudmap_developingGonad_e14.5_ ovary_100 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.79e-03 | 275 | 19 | 3 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_200 | 1.87e-03 | 72 | 19 | 2 | gudmap_developingGonad_P2_ovary_200_k5 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 4.75e-05 | 17 | 18 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | rhinitis (is_marker_for) | 3.58e-04 | 46 | 18 | 2 | DOID:4483 (is_marker_for) | |
| Disease | eosinophil count | 1.60e-03 | 1488 | 18 | 5 | EFO_0004842 | |
| Disease | pancreatic cancer (is_marker_for) | 1.71e-03 | 101 | 18 | 2 | DOID:1793 (is_marker_for) | |
| Disease | asthma (is_marker_for) | 2.65e-03 | 126 | 18 | 2 | DOID:2841 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | 3.55e-03 | 1074 | 18 | 4 | C0006142 | |
| Disease | neutrophil percentage of granulocytes | 8.38e-03 | 228 | 18 | 2 | EFO_0007994 | |
| Disease | basophil count, eosinophil count | 9.32e-03 | 241 | 18 | 2 | EFO_0004842, EFO_0005090 | |
| Disease | eosinophil percentage of leukocytes | 9.89e-03 | 746 | 18 | 3 | EFO_0007991 | |
| Disease | Autistic Disorder | 1.09e-02 | 261 | 18 | 2 | C0004352 | |
| Disease | Antihypertensive use measurement | 1.12e-02 | 265 | 18 | 2 | EFO_0009927 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SVVIPSPCCMFFVSK | 26 | O00175 | |
| CPIVDCIKMVSRTTP | 996 | Q12882 | |
| KIYMTCPDCPSSIPT | 146 | Q9UGM5 | |
| CCSEPPVVKTEMVTI | 866 | O43491 | |
| TISVPYSVMKTCPLS | 581 | Q9P265 | |
| VCTKPMTTCPKSMTY | 696 | P98088 | |
| VPMSFKSAVCVPVSC | 66 | P59991 | |
| TMDYKESCPSVSIPS | 6 | Q96BR1 | |
| CSVLSMVCADPVYKV | 636 | Q13233 | |
| MCCETPPTVTVYVKS | 6 | Q5MJ70 | |
| PMKYSATCKTVVETC | 961 | Q4G0N8 | |
| TDTKSVVCPICASMP | 166 | Q9Y508 | |
| ASGPCKIVMSTVCVY | 346 | Q9UQR0 | |
| SYIVMSPESPVKCGT | 186 | Q8NCP5 | |
| YPCMIKGCTSVVTSE | 2386 | O60281 | |
| TAAVVSAKSYMCPVC | 141 | O75541 | |
| RPETVSMVIYPECLC | 346 | Q05996 | |
| SMVIYPECLCESPVS | 351 | Q05996 | |
| VPIFVCTMAYPTVPC | 556 | Q496Y0 | |
| PCIVSTVPYHCVTPM | 206 | E9PAV3 |